These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22033480)

  • 41. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions.
    Rathinakumar R; Dutta M; Zhu P; Johnson WE; Roux KH
    J Virol; 2012 Feb; 86(3):1820-31. PubMed ID: 22090143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
    McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ
    Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional Delineation of a Protein-Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8.
    Insausti S; Garcia-Porras M; Torralba J; Morillo I; Ramos-Caballero A; de la Arada I; Apellaniz B; Caaveiro JMM; Carravilla P; Eggeling C; Rujas E; Nieva JL
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.
    Cardoso RM; Brunel FM; Ferguson S; Zwick M; Burton DR; Dawson PE; Wilson IA
    J Mol Biol; 2007 Feb; 365(5):1533-44. PubMed ID: 17125793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
    Li D; Liu J; Zhang L; Xu T; Chen J; Wang L; Zhao Q
    Virol Sin; 2015 Dec; 30(6):449-56. PubMed ID: 26715302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Melnychuk L; Ajamian L; Jean-Pierre P; Liang J; Gheorghe R; Wainberg MA; Zaharatos GJ
    Vaccine; 2017 May; 35(20):2736-2744. PubMed ID: 28392143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies.
    Frey G; Chen J; Rits-Volloch S; Freeman MM; Zolla-Pazner S; Chen B
    Nat Struct Mol Biol; 2010 Dec; 17(12):1486-91. PubMed ID: 21076402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5.
    de la Arada I; Julien JP; de la Torre BG; Huarte N; Andreu D; Pai EF; Arrondo JL; Nieva JL
    J Phys Chem B; 2009 Oct; 113(41):13626-37. PubMed ID: 19754136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
    Cleveland SM; Jones TD; Dimmock NJ
    J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
    Perez LG; Costa MR; Todd CA; Haynes BF; Montefiori DC
    J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane-proximal external HIV-1 gp41 motif adapted for destabilizing the highly rigid viral envelope.
    Apellániz B; Ivankin A; Nir S; Gidalevitz D; Nieva JL
    Biophys J; 2011 Nov; 101(10):2426-35. PubMed ID: 22098741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.
    Diomede L; Nyoka S; Pastori C; Scotti L; Zambon A; Sherman G; Gray CM; Sarzotti-Kelsoe M; Lopalco L
    J Virol; 2012 Apr; 86(8):4129-38. PubMed ID: 22301151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.
    Yu Y; Tong P; Li Y; Lu Z; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):117-27. PubMed ID: 24369352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41.
    Apellániz B; Nir S; Nieva JL
    Biochemistry; 2009 Jun; 48(23):5320-31. PubMed ID: 19449801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane.
    Rujas E; Insausti S; García-Porras M; Sánchez-Eugenia R; Tsumoto K; Nieva JL; Caaveiro JM
    J Mol Biol; 2017 Apr; 429(8):1213-1226. PubMed ID: 28300601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
    Cleveland SM; McLain L; Cheung L; Jones TD; Hollier M; Dimmock NJ
    J Gen Virol; 2003 Mar; 84(Pt 3):591-602. PubMed ID: 12604810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1.
    Coutant J; Yu H; Clément MJ; Alfsen A; Toma F; Curmi PA; Bomsel M
    FASEB J; 2008 Dec; 22(12):4338-51. PubMed ID: 18776068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.